Join the National Academy of Medicine and science, technology, and policy professionals from the Washington, D.C., region for breakfast and conversation as we explore emerging neurotechnologies with a focus on how advances in neural sensing, modulation, and adaptive brain–computer systems are reshaping possibilities for treating neurological and psychiatric conditions.
As tools for decoding, stimulating, and potentially optimizing brain function move from research settings toward clinical and commercial deployment, they raise complex questions around safety, personal agency, data governance, equity, regulatory oversight, and responsible integration into health systems. The event is in-person only and will foster cross-sector dialogue on how innovation in neurotechnology can proceed in ways that are scientifically rigorous, ethically grounded, and socially responsive.
Agenda:
- Breakfast & Networking
- Welcome and Introductions by Cara LaPointe, Georgetown University Center for Security and Emerging Technology
- Presentation by John Ngai, National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
- Reflection on Implications for Responsible Innovation and Governance by Anna Wexler, University of Pennsylvania Division of Medical Ethics and Health Policy
- Discussion moderated by Debra Mathews, Johns Hopkins Berman Institute of Bioethics
Register for Bagels and Biotech!
Bagels and Biotech is an initiative of the NAM Action Collaborative on Translating Emerging Science, Technology, and Innovation in collaboration with the National Academies Programs on Biomedical and Health Sciences & Life Sciences and Biotechnology.
